Supplementary table s3 - PowerPoint PPT Presentation
20 o C
Supplementary Table S1. Respiration rates of the mitochondria isolated from the florets of thermogenic male part of the spadices of D. vulgaris . O 2 uptake (nmol O 2 /min/mg protein). Respiration. 20 o C. 35 o C.
By brenna
Supplementary Table S1. GenBank accession numbers of individual RNA segments in TSWV-1, TSWV-2, and TSWV-3 in this study. Supplementary Table S2. List of oligonucleotide primers used for sequencing of TSWV-1, TSWV-2, and TSWV-3.
By betsy
Supplementary Figure S1.
Supplementary Figure S1. Supplementary Figure S1. Determination of the binding mode of the FGFR inhibitor CH5183284/Debio 1347.
By hilde
125 pb
150 pb. 150 pb. 150 pb. 150 pb. 125 pb. 125 pb. 125 pb. 125 pb. 100 pb. 100 pb. 100 pb. 100 pb. 75 pb. 75 pb. 75 pb. 75 pb.
By avivaView Supplementary table s3 PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Supplementary table s3 PowerPoint presentations. You can view or download Supplementary table s3 presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.
Recherches associées pour Supplementary table s3
Supplementary Figure S3
(A). ATP synthase. ATP synthase. PSI+LHCI,PSII-D. PSI+LHCI,PSII-D. PSII-SC. PSII-CP43. PSII-SC. PSII-CP43. LHCII-M. LHCII-M. LHCII-T. LHCII-T. Cytb6f. Cytb6f. (B). kDa. D1. D3. D2. I1. 437. WT. I2. D4. D5. WT. 437. 66 45 36 29 24 20 14. 66 45 36 29 24 20 14.
Supplementary Figure S3
A. Line 1112 no treatment. Line 1112 with azadC. CTCFmutE. RBF-1. E2F. Sp1. CTCFmutE. RBF-1. E2F. Sp1. 34.3 %. 48.1 %. 0. 40. 90. 100. 0. 80. 0. 0. 40. 0. 90. 40. 50. 50. 80. 90. 80. 40. 40. 40. 40. 40. 80. 80. 0. 80. 0. CH 3 %. 0. 33. 100. 77. 0. 66.
Supplementary Figure S3
A. 0.1 ng/ml RANKL. 1 ng/ml RANKL. 10 ng/ml RANKL. B. 0.1 ng/ml RANKL. 1 ng/ml RANKL. 10 ng/ml RANKL. Supplementary Figure S3.
Supplementary Figure S3
Supplementary Figure S3. A. B. HCT116 Cells. SW480 Cells. Cell Size (µm). Cell Size (µm). HMGA1 Knock-down. Control. Control. HMGA1 Knock-down. 100 µm. 100 µm. 100 µm. 100 µm.
Supplementary Figure S3
Supplementary Figure S3. Analysis of mTOR and AKT signaling in breast cancer cell lines treated with dasatinib and rapamycin. MCF7. MDA-MB-231. BT474. 1hr. 24hr. 1hr. 24hr. 1hr. 24hr. Combo. Combo. Combo. Combo. Combo. Combo. DMSO. DMSO. DMSO. DMSO. DMSO. DMSO. Rap.
Figure S3 supplementary
Figure S3 supplementary.
Supplementary Figure S3
Supplementary Figure S3. Stresing et al. A. log [µg/L]. #9. #7. #6. #5. #8. #4. #3. B. 435-L 3. 435-P. poo l. scbl. shPRDX2 clones. 80000000. y = 1584,5 x -3E+06 R 2 = 0,9928. 60000000. RLU. 40000000. 20000000. 0. 0. 10. 20. 30. 40. 50. Number of cells x1000.
Supplementary Fig S3
A. MCF-7EpiR. MCF-7TaxR. siControl. siSIRT6. siControl. siSIRT6. Paclitaxel ( h ):. Epirubicin ( h ). 0. 24. 48. 0. 24. 48. 0. 48. 72. 0. 48. 72. SIRT6. SIRT6. FOXO3a. FOXO3a. p27Kip1. p27Kip1. H3K9ac. Ac-p53. H3K56ac. p53. H3K9Ac. Ac-α-TUBULIN. H3K56Ac.
Supplementary information, Figure S3
ChIP-seq_CEBPD. ChIP-seq_CEBPD. ChIP-seq_CEBPB. ChIP-seq_CEBPB. Upregulated_lncRNAs. Downregulated_lncRNAs. Supplementary information, Figure S3.
Electronic supplementary material S3
Electronic supplementary material S3. a). A. B. B. C 1. C 2. b). R. W. R. L. N. P. P. T. E. T. G. Q. H. T. P. F. L. C. C. N. N. Zn. T. A. C. C. AAGGANALPTT. GLFLKLHGVVRPLSLKTDVIKKRNRGS. ●. ●. ▲. ■. ●. ●. ●. ■. 697. 751. b 3. b 4. a. loop. b 1. b 2.